Kirby KEX Q1 2026 Earnings Strong EPS Beat Amid Modest Stock Decline PMVP Q1 2026 Earnings Narrower Loss Slightly Beats Estimates as Development Advances STOK Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances BGSF Q1 2026 Earnings EPS Misses Estimates Stock Slips 094 NJR Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Regulatory Execution EPR Properties Q1 2026 Earnings EPS Beats Estimates by 11 as Experiential Portfolio Shows Resilience